Status:
RECRUITING
Can Second Resection for pT1 Bladder Cancer be Avoided After Initial En-Bloc Resection With Negative Safety Margins
Lead Sponsor:
Mansoura University
Conditions:
Bladder Cancer Stage I
Eligibility:
All Genders
18-80 years
Brief Summary
The goal of this \[ Can second resection for pT1 bladder carcinoma be safely avoided after initial En-Bloc Resection with negative vertical and horizontal safety margins ? is to assess the impact of a...
Detailed Description
Bladder cancer (BC) is the one of the most prevalent cancer in Egypt representing nearly 30% of all cancers. Approximately 75% of newly diagnosed BC present with non-muscle invasive disease (NMIBC). I...
Eligibility Criteria
Inclusion
- • Patients treated with ERBT and diagnosed with pT1 disease with negative vertical and horizontal safety margins at final pathology.
Exclusion
- Large tumors not suitable for ERBT
- Residual tumor.
- Multicentric tumors ( more than 4 lesions)
- Presence of CIS.
- Positive vertical or horizontal safety margins after initial resection.
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
370 Patients enrolled
Trial Details
Trial ID
NCT05969964
Start Date
July 1 2023
End Date
December 1 2025
Last Update
October 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and nephrology center, Mansoura University
Al Mansurah, Dakahlia Governorate, Egypt, 35516